OverviewSuggest Edit

Remegen is a company that develops biopharmaceutical products. The company focuses on research and development, manufacturing and commercialization of biologics, notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs), enabling patients and clinicians with pharmaceutical products for the treatment of cancer, autoimmune and eye-related diseases.
HQYantai, CN


Remegen is headquartered in
Yantai, China

Location Map

Latest Updates

Employees (est.) (Jan 2022)134(+4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Remegen

Jianmin Fang

Jianmin Fang

Founder, CEO & CSO

Remegen Office Locations

Remegen has an office in Yantai
Show all (1)

Remegen Financials and Metrics

Summary Metrics

Founding Date


Remegen total Funding

$100 m

Remegen latest funding size

$100 m

Time since last funding

2 years ago

Remegen investors

Remegen's latest funding round in March 2020 was reported to be $100 m. In total, Remegen has raised $100 m
Show all financial metrics

Remegen Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Remegen Online and Social Media Presence

Embed Graph

Remegen Frequently Asked Questions

  • When was Remegen founded?

    Remegen was founded in 2008.

  • Who are Remegen key executives?

    Remegen's key executives are Jianmin Fang.

  • How many employees does Remegen have?

    Remegen has 134 employees.

  • Who are Remegen competitors?

    Competitors of Remegen include Kahr medical, ChemoCentryx and Priothera.

  • Where are Remegen offices?

    Remegen has an office in Yantai.

  • How many offices does Remegen have?

    Remegen has 1 office.